Published in Hepatitis Weekly, December 3rd, 2001
Thus far, lactoferrin inhibition of sensitized Kupffer cells has only been proven in murine models, but researchers believe the recombinant protein, which has antibacterial and antifungal properties, could also be used for treating human hepatic disease.
Makoto Yamaguchi and associates at the Nutrition Science Institute of Meiji Dairies Corporation in Japan performed the series of animal model experiments, in which they administered recombinant lactoferrin to mice a day before...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.